WallStreetZenWallStreetZen

NASDAQ: RLAY
Relay Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for RLAY

Based on 2 analysts offering 12 month price targets for Relay Therapeutics Inc.
Min Forecast
$17.00+108.33%
Avg Forecast
$23.50+187.99%
Max Forecast
$30.00+267.65%

Should I buy or sell RLAY stock?

Based on 2 analysts offering ratings for Relay Therapeutics Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their RLAY stock forecasts and price targets.

RLAY stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-02-22
lockedlocked$00.00+00.00%2023-12-11

1 of 1

Forecast return on equity

Is RLAY forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.5%

Forecast return on assets

Is RLAY forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

RLAY revenue forecast

What is RLAY's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$9.0M-64.97%
Avg 2 year Forecast
$7.2M-71.8%
Avg 3 year Forecast
$21.0M-17.81%
RLAY's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

RLAY revenue growth forecast

How is RLAY forecast to perform vs Biotechnology companies and vs the US market?
Company
-9.41%
Industry
38.94%
Market
10.52%
RLAY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
RLAY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

RLAY vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
RLAY$8.16$23.50+187.99%Strong Buy
ZNTL$15.19$33.75+122.19%Strong Buy
BCRX$5.15$11.00+113.59%Strong Buy
ETNB$11.31$27.20+140.50%Buy
CNTA$11.10$9.50-14.41%Buy

Relay Therapeutics Stock Forecast FAQ

Is Relay Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: RLAY) stock is to Strong Buy RLAY stock.

Out of 2 analysts, 1 (50%) are recommending RLAY as a Strong Buy, 1 (50%) are recommending RLAY as a Buy, 0 (0%) are recommending RLAY as a Hold, 0 (0%) are recommending RLAY as a Sell, and 0 (0%) are recommending RLAY as a Strong Sell.

If you're new to stock investing, here's how to buy Relay Therapeutics stock.

What is RLAY's revenue growth forecast for 2024-2026?

(NASDAQ: RLAY) Relay Therapeutics's forecast annual revenue growth rate of -9.41% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.94%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.52%.

Relay Therapeutics's revenue in 2024 is $25,546,000.On average, 4 Wall Street analysts forecast RLAY's revenue for 2024 to be $1,174,052,354, with the lowest RLAY revenue forecast at $104,943,227, and the highest RLAY revenue forecast at $4,197,729,088. On average, 2 Wall Street analysts forecast RLAY's revenue for 2025 to be $945,144,940, with the lowest RLAY revenue forecast at $800,192,107, and the highest RLAY revenue forecast at $1,090,097,773.

In 2026, RLAY is forecast to generate $2,754,234,998 in revenue, with the lowest revenue forecast at $1,705,327,442 and the highest revenue forecast at $4,340,714,235.

What is RLAY's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: RLAY) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is RLAY's Price Target?

According to 2 Wall Street analysts that have issued a 1 year RLAY price target, the average RLAY price target is $23.50, with the highest RLAY stock price forecast at $30.00 and the lowest RLAY stock price forecast at $17.00.

On average, Wall Street analysts predict that Relay Therapeutics's share price could reach $23.50 by Feb 22, 2025. The average Relay Therapeutics stock price prediction forecasts a potential upside of 187.99% from the current RLAY share price of $8.16.

What is RLAY's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: RLAY) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.